Search for Clinical Trial Results

Sponsored By

Neisseriaceae Infections - 12 Studies Found

Status Study
Terminated Study Name: Hormonal Contraception and Risk of Chlamydia and Gonorrhea
Condition:
  • Chlamydia Infection
  • Neisseriaceae Infection

Date: 2004-09-16
Interventions:
  • Drug: Depo Medroxyprogesterone acetate
  • Dru
Recruiting Study Name: Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination
Condition: Infections, Meningococcal
Date: 2016-12-06
Interventions: Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo)
Recruiting Study Name: Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents
Condition: Infections, Meningococcal
Date: 2016-10-25
Interventions:
  • Biological: Meningococcal ABCWY Vaccine

Completed Study Name: Combined Study - Phase 3b MenB Long Term Persistence in Adolescents
Condition: Infections, Meningococcal
Date: 2015-05-06
Interventions: Biological: Meningococcal Group B (rDNA Component adsorbed) (rMenB+OMV NZ) In Group A, intramuscular Boo
Active, not recruiting Study Name: Investigating Meningococcal Vaccines in Adults
Condition:
  • Meningococcal Vaccines
  • Meningococcal Infections
  • Neisseria
    Date: 2015-03-20
    Interventions: Biological: 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics 4CMenB vaccine (Bexsero - Novarti
Recruiting Study Name: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Condition:
  • Meningococcal Disease
  • Pregnancy

Date: 2014-08-20
Interventions: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This pregnancy registry is strictly obs
Completed Study Name: Trial to Assess Immunogenicity and Safety of Novartis Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents
Condition: Meningococcal Disease
Date: 2014-08-06
Interventions:
  • Biological: rMenB+OMV
  • Other: Placebo
Completed Study Name: Safety and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.
Condition: Meningococcal Disease
Date: 2014-06-05
Interventions:
  • Biological: Bexsero® Four
Completed Study Name: Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants
Condition: Infections, Meningococcal
Date: 2014-02-14
Interventions:
  • Biological: Meningococcal group B Vaccine, rMenB+OMV NZ

Completed Study Name: Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)
Condition: Meningococcal Disease
Date: 2013-11-15
Interventions:
  • Biological: MenABCWY+OMV Vacci
Next >>>